Patents Represented by Attorney, Agent or Law Firm Finnegan, Benderson, Farabow, Garrett & Dunner, L.L.P.
  • C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
    Patent number: 6762326
    Abstract: Embodiments of the invention relate to C2-substituted indan-1-ones and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention include compounds of formula I in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for use as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: July 13, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel